{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:33:05Z","timestamp":1773725585675,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.exer.2019.107836","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:38:06Z","timestamp":1571168286000},"page":"107836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pharmacokinetics and intraocular pressure\u2013lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey"],"prefix":"10.1016","volume":"189","author":[{"given":"Anneli","family":"Savinainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery J.","family":"Prusakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marita Larsson","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Rashidzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serene","family":"Josiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107836_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1350-9462(97)00003-7","article-title":"Prostaglandin derivates as ocular hypotensive agents","volume":"17","author":"Alm","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2019.107836_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3109\/02713688409007417","article-title":"The effects of separate and combined topical treatment with timolol maleate and trifluormethazolamide on the intraocular pressure in normal rabbits","volume":"3","author":"Bar-Ilan","year":"1984","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107836_bib3","first-page":"630","article-title":"Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells","volume":"16","author":"Cammarata","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107836_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(98)00828-0","article-title":"Type B and type C natriuretic peptide receptors modulate intraocular pressure in the rabbit eye","volume":"364","author":"Fernandez-Durango","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107836_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.exer.2019.107836_bib6","first-page":"2385","article-title":"Atrial natriuretic peptides. Effects on intraocular pressure, cGMP, and aqueous flow","volume":"30","author":"Korenfeld","year":"1989","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107836_bib7","first-page":"S279","article-title":"Current therapeutic options and treatments in development for the management of primary open-angle glaucoma","volume":"23","author":"Liebmann","year":"2017","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.exer.2019.107836_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/bbrc.1999.0573","article-title":"Functional expression of components of the natriuretic peptide system in human ocular nonpigmented ciliary epithelial cells","volume":"258","author":"Ortego","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2019.107836_bib9","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.04-1527","article-title":"Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation","volume":"46","author":"Ota","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107836_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnmol.2014.00075","article-title":"Guanylyl cyclase\/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C","volume":"7","author":"Pandey","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.exer.2019.107836_bib11","series-title":"Presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology; April 29\u2013May 3, 2018; Honolulu, HI","article-title":"Characterization of SHP639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice (Poster B0034)","author":"Pang","year":"2018"},{"key":"10.1016\/j.exer.2019.107836_bib12","first-page":"1724","article-title":"Presence of functional type B natriuretic peptide receptor in human ocular cells","volume":"37","author":"Pang","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107836_bib13","doi-asserted-by":"crossref","first-page":"P112","DOI":"10.1016\/j.ophtha.2015.10.055","article-title":"Primary open-angle glaucoma suspect Preferred Practice Pattern guidelines","volume":"123","author":"Prum","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107836_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107836_bib15","first-page":"15","article-title":"Natriuretic peptide system in the human retina","volume":"10","author":"Rollin","year":"2004","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107836_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-019-01130-z","article-title":"Rho-associated kinase inhibitors: evolving strategies in glaucoma treatment","author":"Schehlein","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2019.107836_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide","volume":"130","author":"Suga","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2019.107836_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/exer.1997.0403","article-title":"Ocular hypotension induced by intravitreally injected C-type natriuretic peptide","volume":"66","author":"Takashima","year":"1998","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107836_bib19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.exer.2019.107836_bib20","first-page":"2515","article-title":"Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide","volume":"35","author":"Wiederholt","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107836_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.exer.2014.02.004","article-title":"Validation of rebound tonometry for intraocular pressure measurement in the rabbit","volume":"121","author":"Zhang","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107836_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/108076803322472999","article-title":"CNP-induced changes in pHi, cGMP\/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells","volume":"19","author":"Zhong","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519303550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519303550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:04:29Z","timestamp":1757999069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519303550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"alternative-id":["S0014483519303550"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107836","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and intraocular pressure\u2013lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Takeda. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107836"}}